All stock lists
Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
Healthcare · Medical Instruments & Supplies
17.20-0.09 (-0.49%)
Insider Score
––Not scored
AVTR Insider Score
Insiders here have filed 4 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
AVTR Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 1.69 B | 1.58 B | 1.66 B | 1.62 B | 1.68 B |
| Revenue Growth (YoY) | 0.53 % | — | — | — | — |
| Cost of Revenue | 1.16 B | 1.08 B | 1.14 B | 1.10 B | 1.13 B |
| Gross Profit | 537.00 M | 500.70 M | 523.90 M | 526.50 M | 554.10 M |
| SG&A Expense | 415.20 M | 401.20 M | 392.40 M | 390.30 M | 425.30 M |
| R&D Expense | — | — | — | — | — |
| Operating Expenses | 415.20 M | 401.20 M | 392.40 M | 390.30 M | 425.30 M |
| Operating Income | 121.80 M | 99.50 M | 131.50 M | 136.20 M | 128.80 M |
| Pretax Income | 81.20 M | 55.50 M | 80.80 M | -689.50 M | 81.70 M |
| Tax Provision | 43.10 M | 12.20 M | 28.40 M | 22.30 M | 17.00 M |
| Net Income | 38.10 M | 43.30 M | 52.40 M | -711.80 M | 64.70 M |
| EPS (Basic) | 0.06 | 0.06 | 0.08 | -1.04 | 0.09 |
| EPS (Diluted) | 0.06 | 0.06 | 0.08 | -1.04 | 0.09 |
| Shares Outstanding | 676.20 M | 675.70 M | 678.00 M | 681.70 M | 681.50 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.